✦ LIBER ✦

Preliminary Result of Phase I/II Clinical Trial of Docetaxel, Cisplatin, and Fluorouracil Regimen Induction Chemotherapy for Primary Locoregionally Advanced Nasopharyngeal Carcinoma

✍ Scribed by W. Luo; Z. Yu; Q. Zhang; Q. Zhang; Q. Zhou; D. Kang; Y. Guo

Book ID: 118455998
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 47 KB
Volume: 81
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.06.1693

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction chemotherapy with cisplatin/do

Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: A randomised phase II study

✍ Emilio Fonseca; Juan José Grau; Javier Sastre; Jesús María García-Gómez; Antonio 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Phase I trial of combined chemotherapy w

Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck

✍ Mamoru Tsukuda; Yasukazu Mikami; Yuji Tanigaki; Hideaki Katori; Choichi Horiuchi 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 234 KB

Phase II trial of chemotherapy with 5-fl

Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type

✍ Abdelkrim Taamma; Abdelrahim Fandi; Nacer Azli; Pierre Wibault; Nadia Chouaki; A 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## BACKGROUND. The aim of this study was to evaluate the toxicity and efficacy of the combination of 5-fluorouracil, bleomycin, epirubicin, and cisplatin (FBEC) in the treatment of patients with undifferentiated carcinoma of nasopharyngeal type (UCNT). The study included patients with metastatic or

PD.196 Induction chemotherapy followed b

PD.196 Induction chemotherapy followed byconcurrent chemoradiation in advanced squamous cell carcinoma of the head and neck. Results from a phase II study with docetaxel, cisplatin and 5-fluorouracil

✍ I. Katsilieris; E. Stavrinidis; M. Trichas; A. Amous; G. Lagogiannis; G. Faratzi 📂 Article 📅 2005 🏛 Elsevier Science ⚖ 122 KB

Randomized Phase III Trial of Induction

Randomized Phase III Trial of Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil Followed by Surgery Versus Up-Front Surgery in Locally Advanced Resectable Oral Squamous Cell Carcinoma

✍ Zhong, L.-p.; Zhang, C.-p.; Ren, G.-x.; Guo, W.; William, W. N.; Sun, J.; Zhu, H 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 187 KB

Phase II trial of 5-fluorouracil, leucov

Phase II trial of 5-fluorouracil, leucovorin, interferon-α-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma

✍ Barbara K. Temeck; James E. Liebmann; Christopher Theodossiou; Seth M. Steinberg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

## BACKGROUND. Most patients with esophageal carcinoma present with locally advanced disease and a poor prognosis. Surgery or radiation provides palliation for locally advanced esophageal carcinoma. The role of neoadjuvant therapy remains to be defined. We administered neoadjuvant chemotherapy cons